These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8761297)

  • 21. Transgenic mice provide genetic evidence that transforming growth factor alpha promotes skin tumorigenesis via H-ras-dependent and H-ras-independent pathways.
    Jhappan C; Takayama H; Dickson RB; Merlino G
    Cell Growth Differ; 1994 Apr; 5(4):385-94. PubMed ID: 8043512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signalling in the control of liver homeostasis and transformation.
    Amicone L; Terradillos O; Calvo L; Costabile B; Cicchini C; Della Rocca C; Lozupone F; Piacentini M; Buendia MA; Tripodi M
    Oncogene; 2002 Feb; 21(9):1335-45. PubMed ID: 11857077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice.
    Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P
    Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mnt-deficient mammary glands exhibit impaired involution and tumors with characteristics of myc overexpression.
    Toyo-oka K; Bowen TJ; Hirotsune S; Li Z; Jain S; Ota S; Escoubet-Lozach L; Garcia-Bassets I; Lozach J; Rosenfeld MG; Glass CK; Eisenman R; Ren B; Hurlin P; Wynshaw-Boris A
    Cancer Res; 2006 Jun; 66(11):5565-73. PubMed ID: 16740691
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between MYC and transforming growth factor alpha alter the growth and tumorigenicity of liver progenitor cells.
    Cheung RS; Brooling JT; Johnson MM; Riehle KJ; Campbell JS; Fausto N
    Carcinogenesis; 2007 Dec; 28(12):2624-31. PubMed ID: 17698969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
    Kao CY; Factor VM; Thorgeirsson SS
    Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stromal influences on transformation of human mammary epithelial cells overexpressing c-myc and SV40T.
    Valverius EM; Ciardiello F; Heldin NE; Blondel B; Merlo G; Smith G; Stampfer MR; Lippman ME; Dickson RB; Salomon DS
    J Cell Physiol; 1990 Nov; 145(2):207-16. PubMed ID: 2174061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effect of cyclin D1 and c-Myc leads to more aggressive and invasive mammary tumors in severe combined immunodeficient mice.
    Wang Y; Thakur A; Sun Y; Wu J; Biliran H; Bollig A; Liao DJ
    Cancer Res; 2007 Apr; 67(8):3698-707. PubMed ID: 17440082
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice.
    Sandgren EP; Schroeder JA; Qui TH; Palmiter RD; Brinster RL; Lee DC
    Cancer Res; 1995 Sep; 55(17):3915-27. PubMed ID: 7641211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of beta-catenin during hepatocarcinogenesis in transgenic mouse models: relationship to phenotype and tumor grade.
    Calvisi DF; Factor VM; Loi R; Thorgeirsson SS
    Cancer Res; 2001 Mar; 61(5):2085-91. PubMed ID: 11280770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
    Sargent LM; Sanderson ND; Thorgeirsson SS
    Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
    Witty JP; Lempka T; Coffey RJ; Matrisian LM
    Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient induction of focus formation in a subclone of NIH3T3 cells by c-myc and its inhibition by serum and by growth factors.
    Blondel B; Talbot N; Merlo GR; Wychowski C; Yokozaki H; Valverius EM; Salomon DS; Bassin RH
    Oncogene; 1990 Jun; 5(6):857-65. PubMed ID: 2193293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.
    Shiota G; Kawasaki H; Nakamura T; Schmidt EV
    Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):17-24. PubMed ID: 8581343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acceleration of mammary neoplasia in transforming growth factor alpha transgenic mice by 7,12-dimethylbenzanthracene.
    Coffey RJ; Meise KS; Matsui Y; Hogan BL; Dempsey PJ; Halter SA
    Cancer Res; 1994 Apr; 54(7):1678-83. PubMed ID: 8137281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of an antisense transforming growth factor-beta1 transgene reduces tumorigenicity of EMT6 mammary tumor cells.
    Park JA; Wang E; Kurt RA; Schluter SF; Hersh EM; Akporiaye ET
    Cancer Gene Ther; 1997; 4(1):42-50. PubMed ID: 9012450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transforming growth factor alpha and mouse models of human breast cancer.
    Humphreys RC; Hennighausen L
    Oncogene; 2000 Feb; 19(8):1085-91. PubMed ID: 10713694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of cell cycle characteristics and apoptosis in MMTV-myc and MMTV-ras mouse mammary tumors.
    Hundley JE; Koester SK; Troyer DA; Hilsenbeck SG; Barrington RE; Windle JJ
    Cancer Res; 1997 Feb; 57(4):600-3. PubMed ID: 9044833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic mice overexpressing a dominant-negative mutant type II transforming growth factor beta receptor show enhanced tumorigenesis in the mammary gland and lung in response to the carcinogen 7,12-dimethylbenz-[a]-anthracene.
    Böttinger EP; Jakubczak JL; Haines DC; Bagnall K; Wakefield LM
    Cancer Res; 1997 Dec; 57(24):5564-70. PubMed ID: 9407968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.